Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Pseudomonas aeruginosa deploys competitor-specific antagonistic strategies.

Created on 15 Sep 2026

Authors

Ziyang Chen, Ned S Wingreen, Zemer Gitai

Published in

bioRxiv : the preprint server for biology. Apr 17, 2026. Epub Apr 17, 2026.

Abstract

Microbial competition shapes polymicrobial communities, yet it remains unclear whether bacteria deploy fixed or specific antagonistic strategies against different rivals. Here we show that Pseudomonas aeruginosa deploys distinct strategies to outcompete two clinically relevant species, Burkholderia cenocepacia and Staphylococcus aureus. Under matched conditions, competition with B. cenocepacia is mediated by contact-dependent Type VI secretion, whereas competition with S. aureus follows a staged diffusible program of alkyl quinolone-mediated growth inhibition followed by LasA-dependent lysis. Transcriptomic analysis supports a "Swiss Army knife" model of antagonism in which different competitive context triggers distinct subsets of P. aeruginosa's arsenal. Minimal dynamical models verify that contact-dependent killing is effective against slower-growing competitors, whereas a staged strategy of growth inhibition followed by killing via diffusible factors is preferable against faster-growing rivals. Together, these results show that the competitive success of P. aeruginosa depends on competitor-specific antagonistic strategies.

PMID:
42039531
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement